These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19480669)

  • 1. A randomized, double-blind, placebo-controlled trial to assess the efficacy of topiramate in the treatment of post-traumatic stress disorder.
    Mello MF; Yeh MS; Barbosa Neto J; Braga LL; Fiks JP; Mendes DD; Moriyama TS; Valente NL; Costa MC; Mattos P; Bressan RA; Andreoli SB; Mari JJ
    BMC Psychiatry; 2009 May; 9():28. PubMed ID: 19480669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomized controlled trial to study the efficacy of topiramate in a civilian sample of PTSD.
    Yeh MS; Mari JJ; Costa MC; Andreoli SB; Bressan RA; Mello MF
    CNS Neurosci Ther; 2011 Oct; 17(5):305-10. PubMed ID: 21554564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of augmentation topiramate for chronic combat-related posttraumatic stress disorder.
    Lindley SE; Carlson EB; Hill K
    J Clin Psychopharmacol; 2007 Dec; 27(6):677-81. PubMed ID: 18004136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of civilian and combat-related posttraumatic stress disorder with topiramate.
    Andrus MR; Gilbert E
    Ann Pharmacother; 2010 Nov; 44(11):1810-6. PubMed ID: 20923947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.
    Tucker P; Trautman RP; Wyatt DB; Thompson J; Wu SC; Capece JA; Rosenthal NR
    J Clin Psychiatry; 2007 Feb; 68(2):201-6. PubMed ID: 17335317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report.
    Berlant J; van Kammen DP
    J Clin Psychiatry; 2002 Jan; 63(1):15-20. PubMed ID: 11838620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective open-label study of add-on and monotherapy topiramate in civilians with chronic nonhallucinatory posttraumatic stress disorder.
    Berlant JL
    BMC Psychiatry; 2004 Aug; 4():24. PubMed ID: 15315714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate in combat-related posttraumatic stress disorder.
    Alderman CP; McCarthy LC; Condon JT; Marwood AC; Fuller JR
    Ann Pharmacother; 2009 Apr; 43(4):635-41. PubMed ID: 19336652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nefazodone treatment for chronic posttraumatic stress disorder: an open trial.
    Davis LL; Nugent AL; Murray J; Kramer GL; Petty F
    J Clin Psychopharmacol; 2000 Apr; 20(2):159-64. PubMed ID: 10770453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoxetine versus placebo in posttraumatic stress disorder.
    Martenyi F; Brown EB; Zhang H; Prakash A; Koke SC
    J Clin Psychiatry; 2002 Mar; 63(3):199-206. PubMed ID: 11926718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate Monotherapy for Civilian Posttraumatic Stress Disorder: A Controlled Pilot Study.
    Monga V; Petty F; Padala K; Padala PR
    Prim Care Companion CNS Disord; 2023 Oct; 25(5):. PubMed ID: 37857291
    [No Abstract]   [Full Text] [Related]  

  • 12. Topiramate treatment of alcohol use disorder in veterans with posttraumatic stress disorder: a randomized controlled pilot trial.
    Batki SL; Pennington DL; Lasher B; Neylan TC; Metzler T; Waldrop A; Delucchi K; Herbst E
    Alcohol Clin Exp Res; 2014 Aug; 38(8):2169-77. PubMed ID: 25092377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled trial on the efficacy and tolerability of sertraline in Iranian veterans with post-traumatic stress disorder.
    Panahi Y; Moghaddam BR; Sahebkar A; Nazari MA; Beiraghdar F; Karami G; Saadat AR
    Psychol Med; 2011 Oct; 41(10):2159-66. PubMed ID: 21349225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.
    Berlin HA; Koran LM; Jenike MA; Shapira NA; Chaplin W; Pallanti S; Hollander E
    J Clin Psychiatry; 2011 May; 72(5):716-21. PubMed ID: 20816027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label trial of escitalopram in the treatment of posttraumatic stress disorder.
    Robert S; Hamner MB; Ulmer HG; Lorberbaum JP; Durkalski VL
    J Clin Psychiatry; 2006 Oct; 67(10):1522-6. PubMed ID: 17107242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of bulimia nervosa with topiramate in a randomized, double-blind, placebo-controlled trial, part 2: improvement in psychiatric measures.
    Hedges DW; Reimherr FW; Hoopes SP; Rosenthal NR; Kamin M; Karim R; Capece JA
    J Clin Psychiatry; 2003 Dec; 64(12):1449-54. PubMed ID: 14728106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topiramate in the long-term treatment of binge-eating disorder associated with obesity.
    McElroy SL; Shapira NA; Arnold LM; Keck PE; Rosenthal NR; Wu SC; Capece JA; Fazzio L; Hudson JI
    J Clin Psychiatry; 2004 Nov; 65(11):1463-9. PubMed ID: 15554757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topiramate treatment of aggression in female borderline personality disorder patients: a double-blind, placebo-controlled study.
    Nickel MK; Nickel C; Mitterlehner FO; Tritt K; Lahmann C; Leiberich PK; Rother WK; Loew TH
    J Clin Psychiatry; 2004 Nov; 65(11):1515-9. PubMed ID: 15554765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: a preliminary study.
    Davis LL; Jewell ME; Ambrose S; Farley J; English B; Bartolucci A; Petty F
    J Clin Psychopharmacol; 2004 Jun; 24(3):291-7. PubMed ID: 15118483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.